Senores Pharmaceuticals Limited is a global pharmaceutical company engaged in the manufacturing and development of Active Pharmaceutical Ingredients (APIs), Contract Manufacturing (CMO/CDMO), Generics/Biosimilars, and Finished Dosage Forms. With a robust presence in the USA, India, Africa, the Far East, CIS, the Middle East, and Latin America, the company is committed to producing affordable and high-quality complex generics that meet the stringent standards of global food and drug authorities. The formulation site in the USA primarily serves markets including the US, Canada, the EU, South Africa, Saudi Arabia, Israel, and others. Meanwhile, formulation sites in India are approved by 20 African Ministries of Health, as well as multiple authorities in the Middle East, CIS, and Far East countries.

Services include:
– Finished Dosage Forms
– Active Pharmaceutical Ingredients
– Contract Manufacturing (CMO/CDMO)
– Generics/Biosimilars

Senores Pharmaceuticals continues to explore new opportunities to enhance well-being and contribute to the global pharmaceutical landscape. For more information, please visit senorespharma.com.